CAMPBELL, Calif., Sept. 16, 2013 /PRNewswire/ -- Shifamed LLC, a medical technology incubator, announced today that Apama Medical, Inc., one of its privately held portfolio companies, has raised $3.2M in Series A-1 financing.
Broadview Ventures led the financing round and converted its initial investment to Series A-1 equity. Broadview is a Boston-based investment firm focused on accelerating the development of promising technology in cardiovascular and neurovascular disease through targeted investments in early stage ventures.
"We are pleased to have the support of Broadview Ventures with its solid track record of successful investments," shared Amr Salahieh, Founder and Chairman of Shifamed. "In addition, we are grateful for the NSF SBIR Grant that helped fund our breakthrough technology. Apama Medical offers significant medical technology advancement to electrophysiology (EP) therapies and highlights Shifamed's commitment to improving medical procedures in large, proven markets."
Apama Medical, focused on the EP market, offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation (AF) ablation, which is expected to reach $2.0B in 2017.
"Broadview has a long history of supporting promising medical technology," said Christopher H. Colecchi, Managing Director of Broadview Ventures. "Apama has developed a unique platform in the AF Ablation market. We are excited about continuing our relationship and optimistic about the long-term prospects."
Shifamed LLC is a privately held medical technology incubator focused on developing new medical products from concept to commercial release. To learn more about Shifamed, please visit www.shifamed.com.
About Apama Medical
Apama Medical is a privately held medical device company
|SOURCE Shifamed LLC|
Copyright©2012 PR Newswire.
All rights reserved